0
2022
Pulmonary Function Testing Devices Market

Pulmonary Function Testing Devices Market

by Product (Portable PFT Devices, Complete PFT Devices), by Test Type (Spirometry, Peak flow meter, Lung Volume Test, Gas Exchange Testing, Maximal Voluntary Ventilation, Others), by Application (Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, Others), by End user (Hospital, Clinical laboratories, Diagnostic Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A03407
Sep 2022 | Pages: 341
Tables: 200
Charts: 68
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Pulmonary Function Testing Devices Market Research, 2031

The global Pulmonary Function Testing Devices Market size market was valued at $1.9 billion in 2021, and is projected to reach $3.5 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031. Pulmonary function testing is a series of tests that can determine as well as measure the efficacy of inhaling and exhaling functions performed by the lungs. It plays a pivotal role in determining the efficient transfer of oxygen into the blood and helps in diagnosing certain types of lung diseases such as asthma, bronchitis, and emphysema, along with determining the cause of shortness of breath. Some of the common types of pulmonary function tests are spirometry, which measures how much air a person can breathe in and out. It also measures how fast a person can empty the air out of their lungs. This test is done to check how well the oxygen moves from the lungs into the bloodstream.

The overall impact of COVID-19 remains positive on pulmonary function testing system market. Coronavirus causes a huge effect on the lungs and hence the demand for medical equipment or device increases to keep the lung healthy owing to increase in demand of pulmonary test to diagnose the disease or to check the efficacy of the lungs. Furthermore, pandemic increases the demand for pulmonary function test (PFT) tool as it is a valuable tool in the assessment of respiratory disease. Spirometry is the key diagnostic test for airway diseases such as asthma and chronic obstructive pulmonary disease (COPD), and is the most commonly performed test. The other tests include lung volumes and diffusing capacity measurement, impulse oscillometry (IOS), bronchoprovocation, and exercise physiology tests

Pulmonary Function Testing Devices Market, Pulmonary Function Testing Devices Market size, Pulmonary Function Testing Devices Market share, Pulmonary Function Testing Devices Market trends, Pulmonary Function Testing Devices Market growth, Pulmonary Function Testing Devices Market analysis, Pulmonary Function Testing Devices Market forecast, Pulmonary Function Testing Devices Market opportunity

The key factors that drive the Pulmonary Function Testing Devices Market growth are the rise in the prevalence of lung cancer and lung-related disorders; rise in the geriatric population; and the increase in the adoption of technologically advanced medical devices across the world. In addition, rise in the demand for minimally invasive tests for lung diseases is the key factor that boosts the market growth. For instance, according to the World Health Organization, in 2020, chronic obstructive pulmonary disease (COPD) was the third leading cause of death worldwide. It was estimated that around 3.9 million people died due to COPD. Furthermore, the increase in the geriatric population and the rise in the prevalence of chronic lung diseases have increased the demand for pulmonary function testing devices for disease diagnosis across the world which further boosts the Pulmonary Function Testing Devices Market growth.

Moreover, an increase in R&D activity for pulmonary function testing devices, and a rise in healthcare expenditures further boost the growth of the market. However, the high cost of medical devices and a lack of awareness of pulmonary tests hamper the market growth. Conversely, the emerging healthcare market in developing countries is expected to provide Pulmonary Function Testing Devices Market opportunity for the key players during the forecast period.

 The global Pulmonary Function Testing Devices Market size market was valued at $1.9 billion in 2021, and is projected to reach $3.5 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031. TIn addition, the market is segmented on the basis of test type, application, product, end user and region. By test type the market is segmented into spirometry, peak flow meter, lung volume, gas exchange testing, maximal voluntary ventilation and others. On the basis of application, it is segmented into chronic obstructive pulmonary disorders, asthma, chronic shortness of breath, restrictive lung disease, and others. On the basis of product, it is segmented into portable PFT devices and complete PFT systems. By end user the market is segmented into hospitals, diagnostic centers, clinical laboratories, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Product Segment Review

By product, the market is segmented into portable PFT device and complete PFT system, the portable PFT device segment exhibited the largest Pulmonary Function Testing Devices Market share in 2021 and is anticipated to lead during the forecast period. Owing to the rise in the prevalence of lung cancer and other lung-related disorder which increases the demand of non-invasive tests that measure the capacity of lungs. The complete PFT system segment is anticipated to grow at a significant rate during the forecast period.

Pulmonary Function Testing Devices Market

Test type Segment review

By test type, the pulmonary function testing devices market is segmented into spirometry, peak flow meter, lung volume, gas exchange testing, maximal voluntary ventilation and others. In 2021, the spirometry segment accounted for the largest share of the market. The dominance of this segment can be attributed to the increase in the prevalence of lung cancer and other lung-related disorders, due to rise in the environmental pollution.The peak flow meter segment is anticipated to grow at a significant rate during the forecast period.

Pulmonary Function Testing Devices Market

Application Segment Review

By application, the pulmonary function testing devices market is segmented into chronic obstructive pulmonary disorders, asthma, chronic shortness of breath, restrictive lung disease, and others, the chronic obstructive pulmonary disorder segment exhibited the highest growth in 2021, and is anticipated to lead during the forecast period. Owing to the rise in the geriatric population and the increase in the prevalence of COPD, increases the demand of pulmonary function testing devices.

The asthma segment is anticipated to grow at a significant rate during the forecast period. Owing to the rise in the prevalence of allergic conditions and upper respiratory infectious diseases such as asthma.

Pulmonary Function Testing Devices Market

End User Segment Review

By end user, the hospital segment was the highest revenue contributor to the pulmonary function testing devices market. Owing to the increase in the number of patients visit to hospitals for the diagnosis of lung-related disorders.

The clinical laboratories are expected to witness considerable market growth during the forecast period, owing to the growing awareness of the systematic examination of a patient's pulmonary health using chest x-rays, physical exams, arterial blood gas analysis, and a study of the patient's habits and medical history, as well as the need to limit the severity and impact of pulmonary impairments.

Pulmonary Function Testing Devices Market

Region Segment Review 

Pulmonary Function Testing Devices Market

Region wise, the Pulmonary Function Testing Industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a majority of the pulmonary function testing systems market share in 2021 and is anticipated to remain dominant during the forecast period. Owing to the increasing demand for advanced medical devices for the treatment and detection of such diseases and the growing R&D facilities for the approval and development of novel drug therapies & devices.

Asia-Pacific was the second largest contributor to the pulmonary function testing devices market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to rapid increase in the prevalence of chronic lung diseases such as asthma, COPD, shortness of breath and various others, increases the demand of test used to diagnose chronic conditions (spirometry, lung volume, oxygen titration test and various others).

Pulmonary Function Testing Devices Market

The key players that operate in the pulmonary function testing devices market are Chest M.I Inc, Clarity Medical Pvt. Ltd., Cosmed srl, Data Sciences International Inc, Eco Medics AG, Geratherm Medical AG, JK Medical System Pvt. Ltd., Medical Electronic Construction, Medical Equipment Europe GmbH, MGC Diagnostics Corporation, Morgan Scientific Inc, NDD Medical Technologies Inc, Omron Corporation, Pulm One Advanced Medical Devices Ltd., Schiller AG, Koko LLC, and Vyaire Medical Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pulmonary function testing devices market analysis from 2021 to 2031 to identify the prevailing pulmonary function testing devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pulmonary function testing devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pulmonary function testing devices market trends, key players, market segments, application areas, and market growth strategies.

Pulmonary Function Testing Devices Market Report Highlights

Aspects Details
Market Size By 2031 USD 3.5 billion
Growth Rate CAGR of 6.4%
Forecast period 2021 - 2031
Report Pages 341
By Product
  • Portable PFT Devices
    • Type
      • Hardware
      • Software
  • Complete PFT Devices
    • Type
      • Hardware
      • Software
By Test Type
  • Spirometry
  • Peak flow meter
  • Lung Volume Test
  • Gas Exchange Testing
  • Maximal Voluntary Ventilation
  • Others
By Application
  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Chronic Shortness of Breath
  • Restrictive Lung Disease
  • Others
By End user
  • Hospital
  • Clinical laboratories
  • Diagnostic Laboratories
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, UK, Spain, Rest Of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest Of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest Of LAMEA)
Key Market Players MGC Diagnostics Corporation, Ganshorn Medizin Electronic, ndd Medizintechnik AG, Medical Equipment Europe, COSMED srl, SCHILLER, Minato Holdings Inc, CHEST M.I., Inc, NSPIRE HEALTH INC, Morgan Scientific Inc.,
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Portable PFT Devices

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

      • 4.2.4 Portable PFT Devices Pulmonary Function Testing Devices Market by Type

        • 4.2.4.1 Hardware Market size and forecast, by region
        • 4.2.4.2 Software Market size and forecast, by region
    • 4.3 Complete PFT Devices

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

      • 4.3.4 Complete PFT Devices Pulmonary Function Testing Devices Market by Type

        • 4.3.4.1 Hardware Market size and forecast, by region
        • 4.3.4.2 Software Market size and forecast, by region
  • CHAPTER 5: PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Spirometry

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Peak flow meter

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

    • 5.4 Lung Volume Test

      • 5.4.1 Key market trends, growth factors and opportunities

      • 5.4.2 Market size and forecast, by region

      • 5.4.3 Market analysis by country

    • 5.5 Gas Exchange Testing

      • 5.5.1 Key market trends, growth factors and opportunities

      • 5.5.2 Market size and forecast, by region

      • 5.5.3 Market analysis by country

    • 5.6 Maximal Voluntary Ventilation

      • 5.6.1 Key market trends, growth factors and opportunities

      • 5.6.2 Market size and forecast, by region

      • 5.6.3 Market analysis by country

    • 5.7 Others

      • 5.7.1 Key market trends, growth factors and opportunities

      • 5.7.2 Market size and forecast, by region

      • 5.7.3 Market analysis by country

  • CHAPTER 6: PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 Chronic Obstructive Pulmonary Disease

      • 6.2.1 Key market trends, growth factors and opportunities

      • 6.2.2 Market size and forecast, by region

      • 6.2.3 Market analysis by country

    • 6.3 Asthma

      • 6.3.1 Key market trends, growth factors and opportunities

      • 6.3.2 Market size and forecast, by region

      • 6.3.3 Market analysis by country

    • 6.4 Chronic Shortness of Breath

      • 6.4.1 Key market trends, growth factors and opportunities

      • 6.4.2 Market size and forecast, by region

      • 6.4.3 Market analysis by country

    • 6.5 Restrictive Lung Disease

      • 6.5.1 Key market trends, growth factors and opportunities

      • 6.5.2 Market size and forecast, by region

      • 6.5.3 Market analysis by country

    • 6.6 Others

      • 6.6.1 Key market trends, growth factors and opportunities

      • 6.6.2 Market size and forecast, by region

      • 6.6.3 Market analysis by country

  • CHAPTER 7: PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER

    • 7.1 Overview

      • 7.1.1 Market size and forecast

    • 7.2 Hospital

      • 7.2.1 Key market trends, growth factors and opportunities

      • 7.2.2 Market size and forecast, by region

      • 7.2.3 Market analysis by country

    • 7.3 Clinical laboratories

      • 7.3.1 Key market trends, growth factors and opportunities

      • 7.3.2 Market size and forecast, by region

      • 7.3.3 Market analysis by country

    • 7.4 Diagnostic Laboratories

      • 7.4.1 Key market trends, growth factors and opportunities

      • 7.4.2 Market size and forecast, by region

      • 7.4.3 Market analysis by country

    • 7.5 Others

      • 7.5.1 Key market trends, growth factors and opportunities

      • 7.5.2 Market size and forecast, by region

      • 7.5.3 Market analysis by country

  • CHAPTER 8: PULMONARY FUNCTION TESTING DEVICES MARKET, BY REGION

    • 8.1 Overview

      • 8.1.1 Market size and forecast

    • 8.2 North America

      • 8.2.1 Key trends and opportunities

      • 8.2.2 North America Market size and forecast, by Product

        • 8.2.2.1 North America Portable PFT Devices Pulmonary Function Testing Devices Market by Type
        • 8.2.2.2 North America Complete PFT Devices Pulmonary Function Testing Devices Market by Type
      • 8.2.3 North America Market size and forecast, by Test Type

      • 8.2.4 North America Market size and forecast, by Application

      • 8.2.5 North America Market size and forecast, by End user

      • 8.2.6 North America Market size and forecast, by country

        • 8.2.6.1 U.S.
          • 8.2.6.1.1 Market size and forecast, by Product
          • 8.2.6.1.2 Market size and forecast, by Test Type
          • 8.2.6.1.3 Market size and forecast, by Application
          • 8.2.6.1.4 Market size and forecast, by End user
        • 8.2.6.2 Canada
          • 8.2.6.2.1 Market size and forecast, by Product
          • 8.2.6.2.2 Market size and forecast, by Test Type
          • 8.2.6.2.3 Market size and forecast, by Application
          • 8.2.6.2.4 Market size and forecast, by End user
        • 8.2.6.3 Mexico
          • 8.2.6.3.1 Market size and forecast, by Product
          • 8.2.6.3.2 Market size and forecast, by Test Type
          • 8.2.6.3.3 Market size and forecast, by Application
          • 8.2.6.3.4 Market size and forecast, by End user
    • 8.3 Europe

      • 8.3.1 Key trends and opportunities

      • 8.3.2 Europe Market size and forecast, by Product

        • 8.3.2.1 Europe Portable PFT Devices Pulmonary Function Testing Devices Market by Type
        • 8.3.2.2 Europe Complete PFT Devices Pulmonary Function Testing Devices Market by Type
      • 8.3.3 Europe Market size and forecast, by Test Type

      • 8.3.4 Europe Market size and forecast, by Application

      • 8.3.5 Europe Market size and forecast, by End user

      • 8.3.6 Europe Market size and forecast, by country

        • 8.3.6.1 France
          • 8.3.6.1.1 Market size and forecast, by Product
          • 8.3.6.1.2 Market size and forecast, by Test Type
          • 8.3.6.1.3 Market size and forecast, by Application
          • 8.3.6.1.4 Market size and forecast, by End user
        • 8.3.6.2 Germany
          • 8.3.6.2.1 Market size and forecast, by Product
          • 8.3.6.2.2 Market size and forecast, by Test Type
          • 8.3.6.2.3 Market size and forecast, by Application
          • 8.3.6.2.4 Market size and forecast, by End user
        • 8.3.6.3 Italy
          • 8.3.6.3.1 Market size and forecast, by Product
          • 8.3.6.3.2 Market size and forecast, by Test Type
          • 8.3.6.3.3 Market size and forecast, by Application
          • 8.3.6.3.4 Market size and forecast, by End user
        • 8.3.6.4 UK
          • 8.3.6.4.1 Market size and forecast, by Product
          • 8.3.6.4.2 Market size and forecast, by Test Type
          • 8.3.6.4.3 Market size and forecast, by Application
          • 8.3.6.4.4 Market size and forecast, by End user
        • 8.3.6.5 Spain
          • 8.3.6.5.1 Market size and forecast, by Product
          • 8.3.6.5.2 Market size and forecast, by Test Type
          • 8.3.6.5.3 Market size and forecast, by Application
          • 8.3.6.5.4 Market size and forecast, by End user
        • 8.3.6.6 Rest of Europe
          • 8.3.6.6.1 Market size and forecast, by Product
          • 8.3.6.6.2 Market size and forecast, by Test Type
          • 8.3.6.6.3 Market size and forecast, by Application
          • 8.3.6.6.4 Market size and forecast, by End user
    • 8.4 Asia-Pacific

      • 8.4.1 Key trends and opportunities

      • 8.4.2 Asia-Pacific Market size and forecast, by Product

        • 8.4.2.1 Asia-Pacific Portable PFT Devices Pulmonary Function Testing Devices Market by Type
        • 8.4.2.2 Asia-Pacific Complete PFT Devices Pulmonary Function Testing Devices Market by Type
      • 8.4.3 Asia-Pacific Market size and forecast, by Test Type

      • 8.4.4 Asia-Pacific Market size and forecast, by Application

      • 8.4.5 Asia-Pacific Market size and forecast, by End user

      • 8.4.6 Asia-Pacific Market size and forecast, by country

        • 8.4.6.1 Japan
          • 8.4.6.1.1 Market size and forecast, by Product
          • 8.4.6.1.2 Market size and forecast, by Test Type
          • 8.4.6.1.3 Market size and forecast, by Application
          • 8.4.6.1.4 Market size and forecast, by End user
        • 8.4.6.2 China
          • 8.4.6.2.1 Market size and forecast, by Product
          • 8.4.6.2.2 Market size and forecast, by Test Type
          • 8.4.6.2.3 Market size and forecast, by Application
          • 8.4.6.2.4 Market size and forecast, by End user
        • 8.4.6.3 India
          • 8.4.6.3.1 Market size and forecast, by Product
          • 8.4.6.3.2 Market size and forecast, by Test Type
          • 8.4.6.3.3 Market size and forecast, by Application
          • 8.4.6.3.4 Market size and forecast, by End user
        • 8.4.6.4 Australia
          • 8.4.6.4.1 Market size and forecast, by Product
          • 8.4.6.4.2 Market size and forecast, by Test Type
          • 8.4.6.4.3 Market size and forecast, by Application
          • 8.4.6.4.4 Market size and forecast, by End user
        • 8.4.6.5 South Korea
          • 8.4.6.5.1 Market size and forecast, by Product
          • 8.4.6.5.2 Market size and forecast, by Test Type
          • 8.4.6.5.3 Market size and forecast, by Application
          • 8.4.6.5.4 Market size and forecast, by End user
        • 8.4.6.6 Rest of Asia-Pacific
          • 8.4.6.6.1 Market size and forecast, by Product
          • 8.4.6.6.2 Market size and forecast, by Test Type
          • 8.4.6.6.3 Market size and forecast, by Application
          • 8.4.6.6.4 Market size and forecast, by End user
    • 8.5 LAMEA

      • 8.5.1 Key trends and opportunities

      • 8.5.2 LAMEA Market size and forecast, by Product

        • 8.5.2.1 LAMEA Portable PFT Devices Pulmonary Function Testing Devices Market by Type
        • 8.5.2.2 LAMEA Complete PFT Devices Pulmonary Function Testing Devices Market by Type
      • 8.5.3 LAMEA Market size and forecast, by Test Type

      • 8.5.4 LAMEA Market size and forecast, by Application

      • 8.5.5 LAMEA Market size and forecast, by End user

      • 8.5.6 LAMEA Market size and forecast, by country

        • 8.5.6.1 Brazil
          • 8.5.6.1.1 Market size and forecast, by Product
          • 8.5.6.1.2 Market size and forecast, by Test Type
          • 8.5.6.1.3 Market size and forecast, by Application
          • 8.5.6.1.4 Market size and forecast, by End user
        • 8.5.6.2 Saudi Arabia
          • 8.5.6.2.1 Market size and forecast, by Product
          • 8.5.6.2.2 Market size and forecast, by Test Type
          • 8.5.6.2.3 Market size and forecast, by Application
          • 8.5.6.2.4 Market size and forecast, by End user
        • 8.5.6.3 South Africa
          • 8.5.6.3.1 Market size and forecast, by Product
          • 8.5.6.3.2 Market size and forecast, by Test Type
          • 8.5.6.3.3 Market size and forecast, by Application
          • 8.5.6.3.4 Market size and forecast, by End user
        • 8.5.6.4 Rest of LAMEA
          • 8.5.6.4.1 Market size and forecast, by Product
          • 8.5.6.4.2 Market size and forecast, by Test Type
          • 8.5.6.4.3 Market size and forecast, by Application
          • 8.5.6.4.4 Market size and forecast, by End user
  • CHAPTER 9: COMPANY LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top winning strategies

    • 9.3. Product Mapping of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Key developments

  • CHAPTER 10: COMPANY PROFILES

    • 10.1 SCHILLER

      • 10.1.1 Company overview

      • 10.1.2 Company snapshot

      • 10.1.3 Operating business segments

      • 10.1.4 Product portfolio

      • 10.1.5 Business performance

      • 10.1.6 Key strategic moves and developments

    • 10.2 COSMED srl

      • 10.2.1 Company overview

      • 10.2.2 Company snapshot

      • 10.2.3 Operating business segments

      • 10.2.4 Product portfolio

      • 10.2.5 Business performance

      • 10.2.6 Key strategic moves and developments

    • 10.3 NSPIRE HEALTH INC

      • 10.3.1 Company overview

      • 10.3.2 Company snapshot

      • 10.3.3 Operating business segments

      • 10.3.4 Product portfolio

      • 10.3.5 Business performance

      • 10.3.6 Key strategic moves and developments

    • 10.4 MGC Diagnostics Corporation

      • 10.4.1 Company overview

      • 10.4.2 Company snapshot

      • 10.4.3 Operating business segments

      • 10.4.4 Product portfolio

      • 10.4.5 Business performance

      • 10.4.6 Key strategic moves and developments

    • 10.5 ndd Medizintechnik AG

      • 10.5.1 Company overview

      • 10.5.2 Company snapshot

      • 10.5.3 Operating business segments

      • 10.5.4 Product portfolio

      • 10.5.5 Business performance

      • 10.5.6 Key strategic moves and developments

    • 10.6 Morgan Scientific Inc.,

      • 10.6.1 Company overview

      • 10.6.2 Company snapshot

      • 10.6.3 Operating business segments

      • 10.6.4 Product portfolio

      • 10.6.5 Business performance

      • 10.6.6 Key strategic moves and developments

    • 10.7 Ganshorn Medizin Electronic

      • 10.7.1 Company overview

      • 10.7.2 Company snapshot

      • 10.7.3 Operating business segments

      • 10.7.4 Product portfolio

      • 10.7.5 Business performance

      • 10.7.6 Key strategic moves and developments

    • 10.8 Minato Holdings Inc

      • 10.8.1 Company overview

      • 10.8.2 Company snapshot

      • 10.8.3 Operating business segments

      • 10.8.4 Product portfolio

      • 10.8.5 Business performance

      • 10.8.6 Key strategic moves and developments

    • 10.9 CHEST M.I., Inc

      • 10.9.1 Company overview

      • 10.9.2 Company snapshot

      • 10.9.3 Operating business segments

      • 10.9.4 Product portfolio

      • 10.9.5 Business performance

      • 10.9.6 Key strategic moves and developments

    • 10.10 Medical Equipment Europe

      • 10.10.1 Company overview

      • 10.10.2 Company snapshot

      • 10.10.3 Operating business segments

      • 10.10.4 Product portfolio

      • 10.10.5 Business performance

      • 10.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 2. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR PORTABLE PFT DEVICES, BY REGION, 2021-2031 ($MILLION)
    TABLE 3. PULMONARY FUNCTION TESTING DEVICES MARKET FOR PORTABLE PFT DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 4. GLOBAL PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 5. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)
    TABLE 6. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
    TABLE 7. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR COMPLETE PFT DEVICES, BY REGION, 2021-2031 ($MILLION)
    TABLE 8. PULMONARY FUNCTION TESTING DEVICES MARKET FOR COMPLETE PFT DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 9. GLOBAL COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 10. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)
    TABLE 11. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
    TABLE 12. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 13. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SPIROMETRY, BY REGION, 2021-2031 ($MILLION)
    TABLE 14. PULMONARY FUNCTION TESTING DEVICES MARKET FOR SPIROMETRY, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 15. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR PEAK FLOW METER, BY REGION, 2021-2031 ($MILLION)
    TABLE 16. PULMONARY FUNCTION TESTING DEVICES MARKET FOR PEAK FLOW METER, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 17. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR LUNG VOLUME TEST, BY REGION, 2021-2031 ($MILLION)
    TABLE 18. PULMONARY FUNCTION TESTING DEVICES MARKET FOR LUNG VOLUME TEST, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 19. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR GAS EXCHANGE TESTING, BY REGION, 2021-2031 ($MILLION)
    TABLE 20. PULMONARY FUNCTION TESTING DEVICES MARKET FOR GAS EXCHANGE TESTING, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 21. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR MAXIMAL VOLUNTARY VENTILATION, BY REGION, 2021-2031 ($MILLION)
    TABLE 22. PULMONARY FUNCTION TESTING DEVICES MARKET FOR MAXIMAL VOLUNTARY VENTILATION, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 23. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 24. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 25. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 26. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2021-2031 ($MILLION)
    TABLE 27. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 28. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR ASTHMA, BY REGION, 2021-2031 ($MILLION)
    TABLE 29. PULMONARY FUNCTION TESTING DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 30. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CHRONIC SHORTNESS OF BREATH, BY REGION, 2021-2031 ($MILLION)
    TABLE 31. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CHRONIC SHORTNESS OF BREATH, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 32. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR RESTRICTIVE LUNG DISEASE, BY REGION, 2021-2031 ($MILLION)
    TABLE 33. PULMONARY FUNCTION TESTING DEVICES MARKET FOR RESTRICTIVE LUNG DISEASE, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 34. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 35. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 36. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 37. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HOSPITAL, BY REGION, 2021-2031 ($MILLION)
    TABLE 38. PULMONARY FUNCTION TESTING DEVICES MARKET FOR HOSPITAL, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 39. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CLINICAL LABORATORIES, BY REGION, 2021-2031 ($MILLION)
    TABLE 40. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 41. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
    TABLE 42. PULMONARY FUNCTION TESTING DEVICES MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 43. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 44. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 45. PULMONARY FUNCTION TESTING DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 46. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 47. NORTH AMERICA PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 48. NORTH AMERICA COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 49. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 50. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 51. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 52. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 53. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 54. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 55. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 56. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 57. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 58. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 59. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 60. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 61. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 62. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 63. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 64. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 65. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 66. EUROPE PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 67. EUROPE COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 68. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 69. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 70. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 71. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 72. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 73. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 74. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 75. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 76. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 77. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 78. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 79. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 80. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 81. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 82. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 83. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 84. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 85. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 86. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 87. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 88. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 89. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 90. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 91. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 92. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 93. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 94. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 95. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 96. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 97. ASIA-PACIFIC PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 98. ASIA-PACIFIC COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 99. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 100. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 101. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 102. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 103. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 104. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 105. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 106. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 107. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 108. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 109. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 110. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 111. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 112. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 113. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 114. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 115. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 116. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 117. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 118. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 119. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 120. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 121. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 122. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 123. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 124. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 125. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 126. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 127. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 128. LAMEA PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 129. LAMEA COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 130. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 131. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 132. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 133. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 134. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 135. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 136. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 137. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 138. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 139. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 140. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 141. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 142. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 143. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 144. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 145. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 146. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 147. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
    TABLE 148. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
    TABLE 149. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 150.SCHILLER: COMPANY SNAPSHOT
    TABLE 151.SCHILLER: OPERATING SEGMENTS
    TABLE 152.SCHILLER: PRODUCT PORTFOLIO
    TABLE 153.SCHILLER: NET SALES,
    TABLE 154.SCHILLER: KEY STRATERGIES
    TABLE 155.COSMED SRL: COMPANY SNAPSHOT
    TABLE 156.COSMED SRL: OPERATING SEGMENTS
    TABLE 157.COSMED SRL: PRODUCT PORTFOLIO
    TABLE 158.COSMED SRL: NET SALES,
    TABLE 159.COSMED SRL: KEY STRATERGIES
    TABLE 160.NSPIRE HEALTH INC: COMPANY SNAPSHOT
    TABLE 161.NSPIRE HEALTH INC: OPERATING SEGMENTS
    TABLE 162.NSPIRE HEALTH INC: PRODUCT PORTFOLIO
    TABLE 163.NSPIRE HEALTH INC: NET SALES,
    TABLE 164.NSPIRE HEALTH INC: KEY STRATERGIES
    TABLE 165.MGC DIAGNOSTICS CORPORATION: COMPANY SNAPSHOT
    TABLE 166.MGC DIAGNOSTICS CORPORATION: OPERATING SEGMENTS
    TABLE 167.MGC DIAGNOSTICS CORPORATION: PRODUCT PORTFOLIO
    TABLE 168.MGC DIAGNOSTICS CORPORATION: NET SALES,
    TABLE 169.MGC DIAGNOSTICS CORPORATION: KEY STRATERGIES
    TABLE 170.NDD MEDIZINTECHNIK AG: COMPANY SNAPSHOT
    TABLE 171.NDD MEDIZINTECHNIK AG: OPERATING SEGMENTS
    TABLE 172.NDD MEDIZINTECHNIK AG: PRODUCT PORTFOLIO
    TABLE 173.NDD MEDIZINTECHNIK AG: NET SALES,
    TABLE 174.NDD MEDIZINTECHNIK AG: KEY STRATERGIES
    TABLE 175.MORGAN SCIENTIFIC INC.,: COMPANY SNAPSHOT
    TABLE 176.MORGAN SCIENTIFIC INC.,: OPERATING SEGMENTS
    TABLE 177.MORGAN SCIENTIFIC INC.,: PRODUCT PORTFOLIO
    TABLE 178.MORGAN SCIENTIFIC INC.,: NET SALES,
    TABLE 179.MORGAN SCIENTIFIC INC.,: KEY STRATERGIES
    TABLE 180.GANSHORN MEDIZIN ELECTRONIC: COMPANY SNAPSHOT
    TABLE 181.GANSHORN MEDIZIN ELECTRONIC: OPERATING SEGMENTS
    TABLE 182.GANSHORN MEDIZIN ELECTRONIC: PRODUCT PORTFOLIO
    TABLE 183.GANSHORN MEDIZIN ELECTRONIC: NET SALES,
    TABLE 184.GANSHORN MEDIZIN ELECTRONIC: KEY STRATERGIES
    TABLE 185.MINATO HOLDINGS INC: COMPANY SNAPSHOT
    TABLE 186.MINATO HOLDINGS INC: OPERATING SEGMENTS
    TABLE 187.MINATO HOLDINGS INC: PRODUCT PORTFOLIO
    TABLE 188.MINATO HOLDINGS INC: NET SALES,
    TABLE 189.MINATO HOLDINGS INC: KEY STRATERGIES
    TABLE 190.CHEST M.I., INC: COMPANY SNAPSHOT
    TABLE 191.CHEST M.I., INC: OPERATING SEGMENTS
    TABLE 192.CHEST M.I., INC: PRODUCT PORTFOLIO
    TABLE 193.CHEST M.I., INC: NET SALES,
    TABLE 194.CHEST M.I., INC: KEY STRATERGIES
    TABLE 195.MEDICAL EQUIPMENT EUROPE: COMPANY SNAPSHOT
    TABLE 196.MEDICAL EQUIPMENT EUROPE: OPERATING SEGMENTS
    TABLE 197.MEDICAL EQUIPMENT EUROPE: PRODUCT PORTFOLIO
    TABLE 198.MEDICAL EQUIPMENT EUROPE: NET SALES,
    TABLE 199.MEDICAL EQUIPMENT EUROPE: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.PULMONARY FUNCTION TESTING DEVICES MARKET SEGMENTATION
    FIGURE 2.PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031
    FIGURE 3.PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.PULMONARY FUNCTION TESTING DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.PULMONARY FUNCTION TESTING DEVICES MARKET,BY PRODUCT,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 15.PULMONARY FUNCTION TESTING DEVICES MARKET,BY TEST TYPE,2021(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF SPIROMETRY PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PEAK FLOW METER PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF LUNG VOLUME TEST PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF GAS EXCHANGE TESTING PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MAXIMAL VOLUNTARY VENTILATION PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 22.PULMONARY FUNCTION TESTING DEVICES MARKET,BY APPLICATION,2021(%)
    FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ASTHMA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 25.COMPARATIVE SHARE ANALYSIS OF CHRONIC SHORTNESS OF BREATH PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 26.COMPARATIVE SHARE ANALYSIS OF RESTRICTIVE LUNG DISEASE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 28.PULMONARY FUNCTION TESTING DEVICES MARKET,BY END USER,2021(%)
    FIGURE 29.COMPARATIVE SHARE ANALYSIS OF HOSPITAL PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 30.COMPARATIVE SHARE ANALYSIS OF CLINICAL LABORATORIES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 31.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC LABORATORIES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 32.COMPARATIVE SHARE ANALYSIS OF OTHERS PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
    FIGURE 33.PULMONARY FUNCTION TESTING DEVICES MARKET BY REGION,2021
    FIGURE 34.U.S. PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 35.CANADA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 36.MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 37.FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 38.GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 39.ITALY PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 40.UK PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 41.SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 42.REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 43.JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 44.CHINA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 45.INDIA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 46.AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 47.SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 48.REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 49.BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 50.SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 51.SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 52.REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
    FIGURE 53. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 54. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 55. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 56.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 57.COMPETITIVE DASHBOARD
    FIGURE 58.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 59.SCHILLER.: NET SALES ,($MILLION)
    FIGURE 60.COSMED SRL.: NET SALES ,($MILLION)
    FIGURE 61.NSPIRE HEALTH INC.: NET SALES ,($MILLION)
    FIGURE 62.MGC DIAGNOSTICS CORPORATION.: NET SALES ,($MILLION)
    FIGURE 63.NDD MEDIZINTECHNIK AG.: NET SALES ,($MILLION)
    FIGURE 64.MORGAN SCIENTIFIC INC.,.: NET SALES ,($MILLION)
    FIGURE 65.GANSHORN MEDIZIN ELECTRONIC.: NET SALES ,($MILLION)
    FIGURE 66.MINATO HOLDINGS INC.: NET SALES ,($MILLION)
    FIGURE 67.CHEST M.I., INC.: NET SALES ,($MILLION)
    FIGURE 68.MEDICAL EQUIPMENT EUROPE.: NET SALES ,($MILLION)

 
 

This section provides various opinions of top-level CXOs in the pulmonary function testing devices market. According to several interviews conducted, the pulmonary function testing devices market is expected to witness significant growth in the future, owing to the rise in the geriatric population and the increase in the prevalence of lung diseases such as asthma, emphysema, chronic obstructive pulmonary disorders, and various others.

According to the perspectives of CXOs, the pulmonary function testing devices market is expected to witness steady growth in the future. The rise in the geriatric population and the increase in lung cancer disease, along with the rise in healthcare expenditure across the world, are the key factors driving the growth of the market. In addition, the rise in technological advancement and the increase in the number of key players who develop advanced pulmonary function test solutions for disease diagnosis propel the growth of the market. However, the high cost of devices and lack of awareness are expected to hamper the growth of the market to some extent over the forecast period.

On the contrary, growing demand for such devices and the rising economies of developing countries are expected to provide opportunities for the growth of the pulmonary function testing devices market in the future.

Furthermore, North America is expected to witness the highest growth in terms of revenue, owing to advanced healthcare facilities provided by government and private authorities, and rise in R&D facilities for the approval and development of novel medical devices and drug therapies in the region are the factors which propel the growth of the market.

Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to an increase in the geriatric population and the higher prevalence of COPD and other lung-related disorders in developing countries are the key factors which boost the growth of market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The upcoming trends are the rise in the prevalence of lung cancer and lung-related disorders; the rise in the geriatric population, and the increase in adoption of technologically advanced medical devices across the world

A. The forecast period in the report is from 2022 to 2031

A. North America the largest regional market for Pulmonary Function Testing Devices

A. The total market value of the Pulmonary Function Testing Devices market is $ 3,483.3 million in 2031

A. Chest M.I Inc, Clarity Medical Pvt. Ltd., Cosmed srl, Data Sciences International Inc, Eco Medics AG, Geratherm Medical AG, JK Medical System Pvt. Ltd are the top companies to hold the market share in Pulmonary Function Testing Devices

A. The market value of the Pulmonary Function Testing Devices market in 2021 was $1,865.78 Million

A. No, value chain analysis is provided in the Pulmonary Function Testing Devices market report

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Pulmonary Function Testing Devices Market

Start reading instantly.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,840
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Sep 2023 - Sep 2024)
  • Data Pack
  • $4,380
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2023 - Sep 2024)
  • Single User
  • $6,090
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2023 - Sep 2024)
  • Five Users
  • $6,630
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2023 - Sep 2024)
  • Enterprise
    License/PDF

  • $10,500
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2023 - Sep 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers